The company is currently in discussions with a number of governments regarding their specific pandemic planning needs, including governments who are changing their planned immunisation programs. GSK confirmed
Goldman Sachs said: “India presents an attractive region for clinical trials given a population of over one billion, a large number of English-speaking patients, and a well developed
The company said that its new formulation plant is likley to deliver products to over 15 countries. Pharmabiz quoted, Archana Mitra, associate vice president of exports at Bal
Reportedly, under the purchase order, Sinovac is required to deliver an additional 8.57 million doses of Panflu1 (15ug/0.5ml) to the Chinese Central Government, of which 2.33 million doses
Sumavel DosePro delivers subcutaneous sumatriptan, a treatment that provides migraine relief starting within ten minutes for some patients, in a first-of-its-kind needle-free delivery system. Sumavel DosePro is expected
Octapharma said that the FDA’s approval and granting of orphan drug exclusivity of Wilate marks the entrance of the company into the US blood coagulation market, with product
In May 2006, Mannatech filed a lawsuit against Techmedica and Ionx in the US District Court for the Northern District of Texas, Dallas Division, alleging infringement of its
Sirnaomics is developing nanoparticle-based siRNA delivery systems in three generations: the self-assembled nanoparticles, ligand-directed nanoparticles, and infrared-activated nanoparticles, for various types of therapeutic applications. Patrick Lu, president and
Wockhardt will launch the product immediately upon expiration of the patent on June 20, 2011. Levofloxacin is a widely used antibacterial drug and belongs to the fluoroquinolone group,
Ofloxacin is a fluoroquinolone-based antibiotic, which addresses several indications including staph infection, strep throat (Streptococcus), pneumonia, influenza, E Coli, and several sexually transmitted bacterial diseases such as Chlamydia
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.